Figure 2

LI85008F reduces changes in body weight and Body Mass Index in obese subjects. Line diagrams represent mean reduction in body weight (A) and Body Mass Index (B) from baseline to 8 weeks in placebo (n = 20) and LI85008F (n = 21) supplemented groups, respectively. Values represent mean ± SE.